Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Aurinia Pharmaceuticals Inc.(AUPH) | 12,229,500 | 13,044,106 | +814,606 | $181.24M | $221.36M | 10.05% | +$40.12M |
| Spyre Therapeutics, Inc.(SYRE) | 1,892,200 | 1,892,200 | 0 | $95.44M | $167.99M | 7.63% | +$72.55M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,236,027 | 1,236,027 | 0 | $114.18M | $144.70M | 6.57% | +$30.52M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 2,259,889 | 2,259,889 | 0 | $108.81M | $144.52M | 6.56% | +$35.71M |
| Celcuity Inc.(CELC) | 1,050,000 | 1,314,594 | +264,594 | $119.85M | $137.53M | 6.25% | +$17.69M |
| Corcept Therapeutics Incorporated(CORT) | 1,500,000 | 1,500,000 | 0 | $60.47M | $130.43M | 5.92% | +$69.96M |
| PTC Therapeutics, Inc.(PTCT) | 1,500,000 | 1,500,000 | 0 | $102.19M | $122.36M | 5.56% | +$20.16M |
| Lakefront Biotherapeutics NVADR(LKFT) | 3,785,991 | 3,785,991 | 0 | $113.58M | $113.50M | 5.16% | -$75.7K |
| Capricor Therapeutics, Inc.(CAPR) | 3,399,900 | 4,099,900 | +700,000 | $103.36M | $98.73M | 4.48% | -$4.63M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 1,188,624 | 1,568,266 | +379,642 | $83.38M | $98.71M | 4.48% | +$15.32M |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 168,000 | 123,000 | -45,000 | $109.26M | $91.85M | 4.17% | -$17.40M |
| Anaptysbio Inc | 1,330,879 | 1,330,879 | 0 | $73.81M | $89.83M | 4.08% | +$16.02M |
| Immunocore Holdings plcADS(IMCR) | 2,649,368 | 2,649,368 | 0 | $79.88M | $84.12M | 3.82% | +$4.24M |
| COMPASS Pathways plcADS(CMPS) | 4,002,200 | 5,000,000 | +997,800 | $22.13M | $70.75M | 3.21% | +$48.62M |
| ANI Pharmaceuticals, Inc.(ANIP) | 707,500 | 707,500 | 0 | $54.41M | $58.57M | 2.66% | +$4.16M |
| BioNTech SEADS(BNTX) | 470,000 | 470,000 | 0 | $41.77M | $43.73M | 1.99% | +$1.96M |
| Compass Therapeutics, Inc.(CMPX) | 16,790,809 | 17,990,782 | +1,199,973 | $88.82M | $39.40M | 1.79% | -$49.42M |
| Precigen, Inc.(PGEN) | 6,417,500 | 6,417,500 | 0 | $24.84M | $36.58M | 1.66% | +$11.74M |
| Viridian Therapeutics, Inc.(VRDN) | 1,792,626 | 1,792,626 | 0 | $35.06M | $32.93M | 1.50% | -$2.13M |
| Nuvectis Pharma, Inc.(NVCT) | 0 | 1,550,000 | +1,550,000 | $0 | $28.50M | 1.29% | +$28.50M |
| Dianthus Therapeutics, Inc.(DNTH) | 264,692 | 264,692 | 0 | $22.21M | $25.80M | 1.17% | +$3.59M |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 6,521,412 | +6,521,412 | $0 | $23.87M | 1.08% | +$23.87M |
| Atea Pharmaceuticals, Inc.(AVIR) | 4,814,700 | 4,814,700 | 0 | $25.90M | $22.39M | 1.02% | -$3.51M |
| Crescent Biopharma, Inc.(CBIO) | 1,160,000 | 1,160,000 | 0 | $21.31M | $20.88M | 0.95% | -$429.2K |
| Nano Dimension Ltd.ADS(NNDM) | 0 | 14,292,813 | +14,292,813 | $0 | $20.72M | 0.94% | +$20.72M |
| Viking Therapeutics, Inc.(VKTX) | 500,000 | 500,000 | 0 | $16.27M | $19.50M | 0.89% | +$3.23M |
| Nuvation Bio Inc.CL A(NUVB) | 3,149,557 | 3,299,557 | +150,000 | $13.51M | $18.74M | 0.85% | +$5.23M |
| IDEAYA Biosciences, Inc.(IDYA) | 450,000 | 450,000 | 0 | $14.99M | $16.77M | 0.76% | +$1.78M |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 0 | 0 | 0 | $0 | $11.47M | 0.52% | +$11.47M |
| Journey Medical Corporation(DERM) | 1,610,000 | 1,610,000 | 0 | $7.55M | $11.40M | 0.52% | +$3.85M |
| Insmed Incorporated(INSM) | 260,000 | 100,000 | -160,000 | $42.52M | $10.66M | 0.48% | -$31.85M |
| Stoke Therapeutics, Inc.(STOK) | 500,000 | 300,000 | -200,000 | $16.28M | $9.82M | 0.45% | -$6.46M |
| Pliant Therapeutics, Inc.(PLRX) | 6,143,132 | 6,141,261 | -1,871 | $7.74M | $7.00M | 0.32% | -$739.3K |
| Boundless Bio, Inc.(BOLD) | 0 | 2,559,875 | +2,559,875 | $0 | $6.40M | 0.29% | +$6.40M |
| PMV Pharmaceuticals, Inc.(PMVP) | 4,245,085 | 4,245,085 | 0 | $5.26M | $5.69M | 0.26% | +$424.5K |
| Moderna, Inc.(MRNA) | 100,000 | 50,000 | -50,000 | $5.08M | $3.50M | 0.16% | -$1.58M |
| Wave Life Sciences, Inc.SHS(WVE) | 600,000 | 600,000 | 0 | $4.35M | $3.49M | 0.16% | -$864.0K |
| Heron Therapeutics, Inc.(HRTX) | 6,250,000 | 6,250,000 | 0 | $5.00M | $2.67M | 0.12% | -$2.33M |
| LENZ Therapeutics, Inc.(LENZ) | 451,114 | 451,114 | 0 | $4.13M | $2.56M | 0.12% | -$1.57M |
| Altimmune, Inc.(ALT) | 666,022 | 666,022 | 0 | $2.05M | $2.02M | 0.09% | -$26.6K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 100,000 | 100,000 | 0 | $358.0K | $342.0K | 0.02% | -$16.0K |
| Abeona Therapeutics Inc.(ABEO) | 400,000 | 0 | -400,000 | $1.79M | $0 | — | -$1.79M |
| Agios Pharmaceuticals, Inc.(AGIO) | 100,000 | 0 | -100,000 | $3.38M | $0 | — | -$3.38M |
| Arvinas, Inc.(ARVN) | 538,658 | 0 | -538,658 | $5.71M | $0 | — | -$5.71M |
| Biogen Inc.(BIIB) | 35,000 | 0 | -35,000 | $6.42M | $0 | — | -$6.42M |
| Coherus Oncology, Inc.(CHRS) | 1,886,748 | 0 | -1,886,748 | $3.19M | $0 | — | -$3.19M |
| Erasca, Inc.(ERAS) | 200,000 | 0 | -200,000 | $3.24M | $0 | — | -$3.24M |
| Evolus, Inc.(EOLS) | 483,021 | 0 | -483,021 | $1.99M | $0 | — | -$1.99M |
| Fate Therapeutics, Inc.(FATE) | 1,167,773 | 0 | -1,167,773 | $1.40M | $0 | — | -$1.40M |
| Janux Therapeutics, Inc.(JANX) | 500,000 | 0 | -500,000 | $6.95M | $0 | — | -$6.95M |
| Kalvista Pharmaceuticals Inc | 4,573,530 | 0 | -4,573,530 | $92.07M | $0 | — | -$92.07M |
| Kezar Life Sciences Inc COM NEW | 664,314 | 0 | -664,314 | $4.93M | $0 | — | -$4.93M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 399,700 | 0 | -399,700 | $623.5K | $0 | — | -$623.5K |
| Neumora Therapeutics, Inc.(NMRA) | 439,878 | 0 | -439,878 | $857.8K | $0 | — | -$857.8K |
| Nkarta, Inc.(NKTX) | 1,480,823 | 0 | -1,480,823 | $3.12M | $0 | — | -$3.12M |
| UroGen Pharma Ltd.(URGN) | 350,000 | 0 | -350,000 | $6.29M | $0 | — | -$6.29M |